CVS - Company ID 0000064803
The table below shows CVS HEALTH Corp's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $108.40B | $106.10B | $100.43B | $102.87B | $98.92B | $94.59B |
| Cost of revenue | $61.19B | $58.86B | $55.44B | $57.05B | $54.01B | $51.06B |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
CVS HEALTH Corp reported annual revenue of $402.07B for fiscal year 2025. That is up 7.8% from $372.81B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $177.55B (FY 2016) to $402.07B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| - |
| - |
| - |
| - |
| - |
| - |
| Operating income | $3.57B | $4.70B | $4.68B | -$3.21B | $2.38B | $3.37B |
| Income tax | $678.00M | $982.00M | $981.00M | $508.00M | $634.00M | $835.00M |
| Net income | $2.17B | $2.98B | $2.94B | -$3.98B | $1.02B | $1.78B |
| EPS (diluted) | $1.68 | $2.31 | $2.30 | -$3.13 | $0.80 | $1.41 |